Pain Management in Pregnant Women

General Principles

• Use the lowest effective dose for the shortest duration necessary.
• Prefer non-pharmacological methods first when feasible.
• Coordinate with obstetrics to individualize analgesic strategies based on gestational age and fetal risk.
• Pain management in the pregnant population is an actively evolving field. As noted in Campbell Walsh Wein Urology, the traditional analgesic routine has been frequent, small-dose morphine administration - but this is being reassessed.

1. Non-Pharmacological Methods (First Line)

2. Pharmacological Options by Drug Class

A. Acetaminophen (Paracetamol) - Preferred First-Line Analgesic

• Considered the safest analgesic at all stages of pregnancy in standard therapeutic doses.
• Established safety profile with no increase in congenital anomalies at therapeutic doses.
• Recommended as first-line for mild-to-moderate pain throughout pregnancy.
• Caution: Recent studies have raised concerns about prolonged use and neurodevelopmental outcomes (ADHD risk), though data remain inconclusive. Short-term therapeutic use is still considered acceptable.

B. NSAIDs (Ibuprofen, Naproxen, Diclofenac, Ketorolac)

• First trimester: Possible risk of miscarriage and cardiac defects; use cautiously or avoid.
• Second trimester: Relatively safer window, but still use judiciously.
• Third trimester (after 30-32 weeks): CONTRAINDICATED - risk of premature closure of the ductus arteriosus and fetal pulmonary hypertension. Ketorolac, for example, is explicitly contraindicated in pregnancy for this reason. - Campbell Walsh Wein Urology
• Aspirin: Low-dose (75-150 mg) aspirin is actually used therapeutically in pregnancy to prevent pre-eclampsia; analgesic doses are avoided.

C. Opioids (Morphine, Codeine, Oxycodone, Fentanyl, Pethidine/Meperidine)

• Reserved for moderate-to-severe pain when non-opioid options are insufficient.
• Use the lowest effective dose; avoid prolonged use.
• Risks include:
  • Neonatal opioid withdrawal syndrome (NOWS) / neonatal abstinence syndrome (NAS)
  • Neonatal respiratory depression (especially near term)
  • Fetal growth restriction with chronic use
  • Preterm delivery
• For labor analgesia, systemic opioids (IV/IM morphine, pethidine, fentanyl, remifentanil PCA) are used but are less effective than regional analgesia.
• Remifentanil patient-controlled analgesia (PCA) is an increasingly used alternative to epidural for labor - comparisons with epidural show reasonable efficacy, though maternal oxygen desaturation requires monitoring.
• For patients on opioid use disorder (OUD) treatment (methadone, buprenorphine): continue MOUD at the same dose throughout delivery; pain management should be multimodal and opioid-sparing. - Creasy & Resnik's Maternal-Fetal Medicine

D. Local Anesthetics (Regional Techniques)

• Most effective method for labor pain control.
• Provides T10-L1 blockade for first-stage labor; T10-S4 for second stage.
• Programmed Intermittent Epidural Bolus (PIEB) and continuous epidural infusion are the most effective delivery methods.
• Dilute local anesthetic + opioid mixtures (e.g., bupivacaine 0.0625-0.125% + fentanyl) are standard.
• Does NOT increase cesarean section rate when dilute mixtures are used.
• Women considering epidural should be counseled: longer labor duration is possible, increased risk of instrument-assisted delivery, and increased risk of intrapartum fever. - Creasy & Resnik's Maternal-Fetal Medicine

• "Single-shot" spinal or combined spinal-epidural (CSE) is appropriate for second-stage or when pain relief is initiated close to delivery.
• Faster onset than epidural alone.

• Multimodal analgesia is the standard.
• Intrathecal morphine remains a key component.
• IV dexamethasone reduces post-cesarean pain (2025 meta-analysis, PMID 40398157).
• Scheduled acetaminophen + NSAIDs (when safe, i.e., postpartum) + regional techniques.

E. Gabapentinoids (Gabapentin, Pregabalin)

• Used for neuropathic pain in pregnancy when first-line agents fail.
• Risks: Associations with neonatal intensive care admissions, possible congenital anomalies - data still inconclusive per 2024 systematic reviews.
• Use reserved for specialist management; amitriptyline is often preferred first for neuropathic pain in pregnancy.

F. Corticosteroids

• Used for specific indications (e.g., fetal lung maturity, inflammatory conditions).
• Short courses acceptable; prolonged use associated with growth restriction and adrenal suppression.

G. Muscle Relaxants

• Limited data in pregnancy; generally avoided unless benefit clearly outweighs risk.

3. Pain by Clinical Scenario

Labor Pain

• Preferred: Regional analgesia (epidural, CSE).
• Alternatives: Systemic opioids (morphine, pethidine, remifentanil PCA), TENS, hydrotherapy, breathing techniques.
• Neuraxial techniques offer superior pain control and can be converted to surgical anesthesia if cesarean becomes necessary.

Renal Colic / Ureteral Stones

• 50-80% pass spontaneously with hydration and analgesia.
• Traditional approach: Small-dose IV morphine.
• Avoid: Ketorolac and other NSAIDs (contraindicated).
• Surgical intervention (stent, PCN drainage) if pain is uncontrolled or there is obstruction + infection. - Campbell Walsh Wein Urology

Back Pain / Pelvic Girdle Pain

• Physiotherapy, exercise, supportive belts.
• Acetaminophen if pharmacological treatment needed.
• Avoid prolonged NSAID use; avoid in third trimester.

Neuropathic Pain

• Amitriptyline (preferred first-line in pregnancy).
• Gabapentin/pregabalin as alternative under specialist guidance.
• No specific NICE/ACOG guidelines exist for neuropathic pain in pregnancy specifically.

Headache / Migraine

• Acetaminophen for acute attacks.
• Avoid triptans (limited data, generally avoided).
• Avoid ergotamine (contraindicated - vasoconstriction risk).
• Magnesium IV/IM can be used (also shows benefit in labor - PMID 40979606).

Chronic Pain (Pre-existing)

• ACOG recommends minimizing or avoiding opioids; explore non-opioid multimodal strategies.
• Patients on opioids should be managed in specialist antenatal clinics with anesthetic assessment. - Maudsley Prescribing Guidelines in Psychiatry

4. Summary Table - Drug Safety by Trimester

5. Special Population: OUD in Pregnancy (2025 Consensus)

• Continue buprenorphine or methadone throughout the peripartum period (do not stop MOUD).
• Anticipate higher opioid requirements intrapartum.
• Multimodal, opioid-sparing strategies are preferred.
• Neuraxial analgesia is strongly recommended for labor.
• Multidisciplinary team management (obstetrics, anesthesiology, addiction medicine, social work).

• A 2026 PROSPECT systematic review (PMID 41693258) updated post-cesarean pain management recommendations, reinforcing multimodal neuraxial + systemic analgesia.
• Concerns about acetaminophen and neurodevelopmental outcomes remain active research areas but do not currently change clinical guidance for short-term therapeutic use.